These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 22821812

  • 1. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer.
    Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Onoyama M, Ohnishi M, Ohara E, Higashi Y, Tanaka S, Yasui W, Chayama K.
    Int J Cancer; 2013 Feb 15; 132(4):813-23. PubMed ID: 22821812
    [Abstract] [Full Text] [Related]

  • 2. Mesenchymal stem cells enhance growth and metastasis of colon cancer.
    Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Higashi Y, Tanaka S, Yasui W, Chayama K.
    Int J Cancer; 2010 Nov 15; 127(10):2323-33. PubMed ID: 20473928
    [Abstract] [Full Text] [Related]

  • 3. Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma.
    Kitadai Y, Sasaki T, Kuwai T, Nakamura T, Bucana CD, Fidler IJ.
    Am J Pathol; 2006 Dec 15; 169(6):2054-65. PubMed ID: 17148668
    [Abstract] [Full Text] [Related]

  • 4. Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma.
    Takigawa H, Kitadai Y, Shinagawa K, Yuge R, Higashi Y, Tanaka S, Yasui W, Chayama K.
    Cancer Sci; 2016 May 15; 107(5):601-8. PubMed ID: 26865419
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
    Lev DC, Kim SJ, Onn A, Stone V, Nam DH, Yazici S, Fidler IJ, Price JE.
    Clin Cancer Res; 2005 Jan 01; 11(1):306-14. PubMed ID: 15671560
    [Abstract] [Full Text] [Related]

  • 6. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.
    Sumida T, Kitadai Y, Shinagawa K, Tanaka M, Kodama M, Ohnishi M, Ohara E, Tanaka S, Yasui W, Chayama K.
    Int J Cancer; 2011 May 01; 128(9):2050-62. PubMed ID: 21387285
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ.
    Clin Cancer Res; 2003 Dec 15; 9(17):6534-44. PubMed ID: 14695158
    [Abstract] [Full Text] [Related]

  • 8. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S, Naot D, Callon K, Porteous F, Horne A, Wattie D, Watson M, Cornish J, Browett P, Grey A.
    J Bone Miner Res; 2007 Nov 15; 22(11):1679-89. PubMed ID: 17663639
    [Abstract] [Full Text] [Related]

  • 9. Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma.
    Katayama R, Huelsmeyer MK, Marr AK, Kurzman ID, Thamm DH, Vail DM.
    Cancer Chemother Pharmacol; 2004 Jul 15; 54(1):25-33. PubMed ID: 15108021
    [Abstract] [Full Text] [Related]

  • 10. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis.
    Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM, Lam PY.
    Stem Cells; 2013 Jan 15; 31(1):146-55. PubMed ID: 23034897
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y, Jia L, Wang X, Tan X, Xu J, Deng Z, Jiang T, Rainov NG, Li B, Ren H.
    Int J Oncol; 2011 Feb 15; 38(2):555-69. PubMed ID: 21152856
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L, Ti X, Krause U, Hai B, Zhao Y, Yang Z, Liu F.
    Stem Cells; 2012 Dec 15; 30(12):2810-9. PubMed ID: 23034983
    [Abstract] [Full Text] [Related]

  • 13. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
    McGary EC, Onn A, Mills L, Heimberger A, Eton O, Thomas GW, Shtivelband M, Bar-Eli M.
    J Invest Dermatol; 2004 Feb 15; 122(2):400-5. PubMed ID: 15009722
    [Abstract] [Full Text] [Related]

  • 14. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
    Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T.
    Cancer; 2005 May 01; 103(9):1800-9. PubMed ID: 15786421
    [Abstract] [Full Text] [Related]

  • 15. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.
    Wang HH, Cui YL, Zaorsky NG, Lan J, Deng L, Zeng XL, Wu ZQ, Tao Z, Guo WH, Wang QX, Zhao LJ, Yuan ZY, Lu Y, Wang P, Meng MB.
    Cancer Lett; 2016 Jun 01; 375(2):349-359. PubMed ID: 26996301
    [Abstract] [Full Text] [Related]

  • 16. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
    Pietras K, Pahler J, Bergers G, Hanahan D.
    PLoS Med; 2008 Jan 29; 5(1):e19. PubMed ID: 18232728
    [Abstract] [Full Text] [Related]

  • 17. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6.
    Lin JT, Wang JY, Chen MK, Chen HC, Chang TH, Su BW, Chang PJ.
    Exp Cell Res; 2013 Aug 15; 319(14):2216-29. PubMed ID: 23751564
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
    McCarty MF, Somcio RJ, Stoeltzing O, Wey J, Fan F, Liu W, Bucana C, Ellis LM.
    J Clin Invest; 2007 Aug 15; 117(8):2114-22. PubMed ID: 17641778
    [Abstract] [Full Text] [Related]

  • 19. Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.
    Kim SJ, Uehara H, Yazici S, Busby JE, Nakamura T, He J, Maya M, Logothetis C, Mathew P, Wang X, Do KA, Fan D, Fidler IJ.
    J Natl Cancer Inst; 2006 Jun 07; 98(11):783-93. PubMed ID: 16757703
    [Abstract] [Full Text] [Related]

  • 20. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
    Kinoshita K, Nakagawa K, Hamada J, Hida Y, Tada M, Kondo S, Moriuchi T.
    Int J Oncol; 2010 Oct 07; 37(4):869-77. PubMed ID: 20811709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.